Search company, investor...


Seed VC | Alive

Total Raised


Last Raised

$2.37M | 2 yrs ago

About MyC MedTech

MyC MedTech is a technology company focused on the healthcare sector. It provides a cloud platform designed to manage health programs and medical facilities, offering services such as health and wellness programs, occupational health clinics, medical facilities management, clinical governance, case management, and health intelligence. The company primarily serves sectors such as occupational health clinics, mining, energy, maritime, government, humanitarian, and medical service providers. It is based in Montreuil, France.

Headquarters Location

113 avenue President Salvador Allende

Montreuil, 93100,


+33 764724796



Expert Collections containing MyC MedTech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MyC MedTech is included in 1 Expert Collection, including Digital Health.


Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

MyC MedTech Frequently Asked Questions (FAQ)

  • Where is MyC MedTech's headquarters?

    MyC MedTech's headquarters is located at 113 avenue President Salvador Allende, Montreuil.

  • What is MyC MedTech's latest funding round?

    MyC MedTech's latest funding round is Seed VC.

  • How much did MyC MedTech raise?

    MyC MedTech raised a total of $2.37M.

  • Who are the investors of MyC MedTech?

    Investors of MyC MedTech include Elaia Partners.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.